What’s Moving These Hot Stocks: Cray, Jazz Pharmaceuticals, Amazon, Ariba
Cray Inc. (NASDAQ:CRAY) shares soar (currently up 54 percent from Tuesday’s close) following its impressive first quarter statement. The veteran maker of computers is crediting its tech sale to Intel on Wednesday, and orders from the Energy Department’s research facility at Oak Ridge, for its strong showing. In addition, Cray offers its 2012 revenue guidance in the range of $430 million to $450 million, which tops consensus of $404 million by a far cry.
Jazz Pharmaceuticals, Inc. (NASDAQ:JAZZ) is being lavishly praised by Jefferies, which predicts that the pharma’s purchase of EUSA accrete 76 cents to its fiscal year 2013 earnings forecast, and also should further separate it from Xyrem. Further, the analyst says that Jazz is one of its top picks, as it raises the price target to $74.
Amazon.com Inc. (NASDAQ:AMZN): eBay (NASDAQ:EBAY) is beefing up its Indian e-commerce investments, as it attempts to rival market leader Flipkart and several other local players. It’s hoped that linking up with PayPal will provide an advantage in India, where cash-on-delivery dominates payment methods, even though Amazon’s recent creation, Junglee.com, could casue some trepidation.
Ariba Inc. (NASDAQ:ARBA) shares are soaring to ten-year highs after the release of its solid fiscal second quarter report, which featured a 59 percent rise in sales, at its business e-commerce network. Also, the firm’s effective changeover to a cloud model for its spend-management products was evidenced by an increase of 32 percent in subscription software sales. Fiscal year 2012 revenue guidance of between $525 million and $535 million was reprted during the earning conference call, along with earnings per share of 96 cents to $1, against a consensus of $528.2 million and 95 cents, respectively.
Allscripts Healthcare Solutions, Inc.’s (NASDAQ:MDRX) really bad day was reinforced by downgrades from UBS to Neutral with a price target of $10, Barclay lowering to Equalwieght, and Cowen and Piper Jaffray to Neutral. The catalyst for the actions was the company’s first quarter pre-announcement and the rearrangement of its management.
Want news like this in real-time so you can get an edge? Click here for Wall St. Cheat Sheet Pro.